Posted on February 28th, 2012 by
A new study, reported here at the American Academy of Pain Medicine 28th Annual Meeting, shows that a low dose of the opioid antagonist naltrexone significantly reduces daily pain in patients with fibromyalgia…Asked to comment on the findings, session moderator James Watson, MD, from the Mayo Clinic in Rochester, Minnesota, said that "it is pretty novel as a treatment. I think the data were exciting, actually."
Medscape, by Kate Johnson, 02/27/2012
You must be logged-in to the site to post a comment.